Abstract
Cerenkov luminescence tomography (CLT) is a promising imaging tool for obtaining three-dimensional (3D) non-invasive visualization of the in vivo distribution of radiopharmaceuticals. However, the reconstruction performance remains unsatisfactory for biomedical applications because the inverse problem of CLT is severely ill-conditioned and intractable. In this study, therefore, a novel non-negative iterative convex refinement (NNICR) approach was utilized to improve the CLT reconstruction accuracy, robustness as well as the shape recovery capability. The spike and slab prior information was employed to capture the sparsity of Cerenkov source, which could be formalized as a non-convex optimization problem. The NNICR approach solved this non-convex problem by refining the solutions of the convex sub-problems. To evaluate the performance of the NNICR approach, numerical simulations and in vivo tumor-bearing mice models experiments were conducted. Conjugated gradient based Tikhonov regularization approach (CG-Tikhonov), fast iterative shrinkage-thresholding algorithm based Lasso approach (Fista-Lasso) and Elastic-Net regularization approach were used for the comparison of the reconstruction performance. The results of these experiments demonstrated that the NNICR approach obtained superior reconstruction performance in terms of location accuracy, shape recovery capability, robustness and in vivo practicability. It was believed that this study would facilitate the preclinical and clinical applications of CLT in the future.
Highlights
C ERENKOV radiation emerges when a charged particle moves faster than the speed of light in the propagation medium [1]
The reconstruction performance of the non-negative iterative convex refinement (NNICR) approach was evaluated in terms of location error, shape similarity, robustness and in vivo practicability using numerical simulations and in vivo experiments
Quantitative analysis demonstrated that the reconstruction result of NNICR had the minimum Location error (LE) of 0.40 mm for S1 and 0.66 mm for S2 compared with the other approaches
Summary
C ERENKOV radiation emerges when a charged particle moves faster than the speed of light in the propagation medium [1]. It can be employed for in vivo animal optical imaging as a new imaging modality named Cerenkov luminescence imaging (CLI), first reported in 2009 [2]. CLI combines the advantages of optical imaging and radionuclide imaging, which is attractive for biomedical applications [10]. Cerenkov luminescence tomography (CLT), a novel 3D optical imaging technique, has been developed by combining the CLI
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.